D.E. Shaw & Co
GEN

D.E. Shaw & Co’s Genesis Healthcare, Inc. GEN Stock Holding History

D.E. Shaw & Co’s Portfolio GEN Stock Details GEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-10,700
Closed -$13K – 4106
2019
Q2 		$13K Sell
10,700
-1,178
-10% -$1.5K ﹤0.01% 3626
2019
Q1 		$17K Sell
11,878
-542,665
-98% -$805K ﹤0.01% 3543
2018
Q4 		$654K Sell
554,543
-4,633
-0.8% -$6.87K ﹤0.01% 2937
2018
Q3 		$755K Buy
559,176
+99,310
+22% +$157K ﹤0.01% 2865
2018
Q2 		$1.05M Buy
459,866
+111,478
+32% +$215K ﹤0.01% 2678
2018
Q1 		$526K Sell
348,388
-132,520
-28% -$155K ﹤0.01% 2859
2017
Q4 		$367K Buy
480,908
+78,905
+20% +$70.5K ﹤0.01% 3146
2017
Q3 		$466K Buy
402,003
+40,641
+11% +$51.2K ﹤0.01% 2951
2017
Q2 		$629K Buy
361,362
+52,841
+17% +$112K ﹤0.01% 2697
2017
Q1 		$815K Buy
308,521
+121,839
+65% +$438K ﹤0.01% 2447
2016
Q4 		$794K Buy
186,682
+144,796
+346% +$477K ﹤0.01% 2595
2016
Q3 		$112K Sell
41,886
-5,722
-12% -$13.2K ﹤0.01% 3279
2016
Q2 		$84K Sell
47,608
-105,189
-69% -$215K ﹤0.01% 3271
2016
Q1 		$354K Sell
152,797
-37,828
-20% -$85.6K ﹤0.01% 2949
2015
Q4 		$662K Buy
190,625
+152,610
+401% +$731K ﹤0.01% 2909
2015
Q3 		$233K Buy
38,015
+25,198
+197% +$171K ﹤0.01% 3442
2015
Q2 		$85K Sell
12,817
-13,409
-51% -$90.4K ﹤0.01% 3664
2015
Q1 		$187K Buy
+26,226
New +$198K ﹤0.01% 3460

Other funds holding GEN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
V3 Capital Management Dallas, Texas $33.4M AUM 5.9% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FWC
First Washington Corp Seattle, Washington $353M AUM 41.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

D.E. Shaw & Co's GEN Position: Q3 2019 in Review

D.E. Shaw & Co sold out of Genesis Healthcare, Inc. (GEN) in Q3 2019, closing a stake of 10,700 shares — an estimated $13K sold.

D.E. Shaw & Co first reported a position in GEN in Q1 2015 and held it in 18 quarters. The position peaked at $1.05M in Q2 2018. 74 funds tracked by Wall St. Rank hold GEN as of Q3 2019.

  • D.E. Shaw & Co reported no remaining Genesis Healthcare, Inc. position as of Q3 2019 after selling out during the quarter.
  • D.E. Shaw & Co sold 10,700 Genesis Healthcare, Inc. shares in Q3 2019, an estimated $13K.
  • D.E. Shaw & Co first reported a position in Genesis Healthcare, Inc. in Q1 2015 and held it in 18 quarters.
  • D.E. Shaw & Co's Genesis Healthcare, Inc. position peaked at $1.05M in Q2 2018.
  • 74 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q3 2019.

Based on D.E. Shaw & Co's 13F filing for Q3 2019, filed 14 Nov 2019.